Akebia Therapeutics (AKBA) Stock Price
$2.95 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
3 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Akebia Therapeutics, AI stock picks, stock alerts and much more.
AKBA AI Stock Analysis
AI stock analysis for AKBA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Akebia Therapeutics (AKBA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Akebia Therapeutics (AKBA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Akebia Therapeutics (AKBA), currently trading at $2.95, will... Sign up to access price prediction.
About AKBA
-
Akebia Therapeutics, Inc.
-
Symbol
AKBA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
782.2M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
AKBA Alternative Data
Web Traffic
Akebia Therapeutics receives an estimated 10978 monthly visitors to akebia.com, which is down by -17.9% over the last month.
-
Web Traffic
10978
-
Change from Previous Month
17.9%
-
3 Month Change
48.8%
-
YoY Change
48.8%
Twitter Followers
Akebia Therapeutics has 2,051 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.
-
Twitter Followers
2051
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Facebook Engagement
Akebia Therapeutics has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Instagram Followers
Akebia Therapeutics has 437 Instagram Followers on its main Instagram account, up by 0.7% over the last month.
-
Instagram Followers
437
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
2.1%
-
YoY Change
2.1%
LinkedIn Followers
39,753 are following Akebia Therapeutics on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
39753
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Job Postings
Akebia Therapeutics currenly has an estimated 10 open job postings, up by 25% over the last month.
-
Job Postings
10
-
Daily Change
0%
-
1 Month Change
25%
-
3 Month Change
9.1%
-
YoY Change
9.1%
LinkedIn Employees
According to LinkedIn, Akebia Therapeutics has 271 employees, up by 0.4% over the last month.
-
LinkedIn Employees
271
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
2.3%
-
YoY Change
2.3%
Reddit Mentions
Akebia Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Akebia Therapeutics is 54 out of 100 (neutral).
-
Business Outlook
54
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Akebia Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
AKBA Financials
AKBA Key Metrics
-
Total Revenue
$46.5M
-
Net Income
-$22.8M
-
Earnings per Share
-$0.11
-
Free cash flow
-$4.5M
-
EBITDA
-$6.6M
-
EBITDA Ratio
-0.141558
-
Total Assets
$220.7M
AKBA 2-year Revenue & Income
AKBA 2-year Free Cash Flow
AKBA Technicals
AKBA SMA
AKBA RSI
FAQ
What's the current price of Akebia Therapeutics (AKBA) Stock?
The price of an Akebia Therapeutics (AKBA) share is $2.95.
What's the market cap of Akebia Therapeutics?
The current market cap of Akebia Therapeutics is 782.2M.
What are some stocks similar to Akebia Therapeutics (AKBA) that investors often compare it to?
Akebia Therapeutics (AKBA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Akebia Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Akebia Therapeutics' stock price to be around $2.94 in 2026. Starting from the current price of $2.95, this represents a 0.5% change in price, indicating a neutral outlook for the stock.
How to buy Akebia Therapeutics (AKBA) Stock?
Akebia Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Akebia Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.